Date: Fri, 07 Feb 2003 03:52:04 -2000 From: "Bill Singer" <junglez@uu.is> To: <cvs-all@freebsd.org> Cc: <kmtrip@io.com>, <floydhais@usaonline.net>, <jeffssweet@aol.com>, <sales@decoratorsbox.com>, <david_weaver@mgc-cedia.com>, <dkujawa@hotmail.com>, <bartman4d@rocketmail.com>, <s.g.trapp@worldnet.att.net>, <kayslo@charter.net>, <newsboys_17@yahoo.com.au> Subject: Building It Correctly30126 Message-ID: <000054665e25$00006b4f$000014ca@dcf.pt>
next in thread | raw e-mail | index | archive | help
MRI Scanning software company gets funded - Sales now will reach millions in current year. BUY NASDAQ: MSGL (OTC BB) Medical Technology Sector CANONSBURG, Pa.--(BUSINESS WIRE)--Feb. 5, 2003 -MicroSignal Corp. (OTC BB: MSGL) announced that it has applied for a five-year, collateralized loan in the amount of $1.5 million and is currently being reviewed by lending institutions in Italy and Switzerland. Under terms of the agreement, the company will issue treasury shares to secure the loan. The shares would be held in trust until the loan is repaid and may not be deposited into a brokerage account for sale by the lender without proof of default by the company. The application terms are a five-year period at 5.5 % interest with interest- only payments during the first year. The company is seeking favorable financing through this and other sources to launch an aggressive marketing and sales campaign with the intent to develop national sales channels to promote MicroSignal's SLICES(TM) technology, used in MRI imaging. Proceeds from funding efforts will be further used to enhance the base technology. MRI Scanning Software Systems Groundbreaking Upgrade Allows 10X more Resolution, at 10% of the cost of a new machine; A Proven market of $1.3B exists for this product. The product is patented, FDA approved and currently just beginning to be implemented at many major institutions. The software allows for MRI resolutions of up to 1.3 Tesla’s compared to existing clarity of .5 Tesla’s. OTCBB: MSGL is poised to move quickly with solid fundamentals now in place. Trading Symbol--------MSGL Exchange Listing------NASDAQ OTCBB Capital Structure-----Total Float/DTC 5.8m, of which 4.4 million are tightly held/friendly Recent High-----------$0.40 Recent Low------------$0.08 30-day Avg Volume-----40,000 30-day price target---$0.50 NASDAQ OTCBB: MSGL - Listed Medical Technology MRI Software Company MSGL – Developers of a Revolutionary MRI upgrade software package (currently being implemented in facilities across the U.S.) that produces images with up to 10X more clarity and resolution than standard MRI processing software at a fraction of the price. MSGL’s ground-breaking SLICES(TM) software manipulates raw data matrices obtained through the MRI scanning process. Through the use of advanced calculations (MicroSignal's EXACT method), SLICES(TM) is able to produce images that boast up to 10 times more clarity and resolutions than standard MRI processing software. In addition to superior image quality, and because of the method of processing, SLICES(TM) is able to significantly reduce patient scan time and the need for patient call backs and rescanning. These factors also can contribute to a reduction in film consumption of up to 40%. At the end of 2002, there were approximately 10,500 MRI (magnetic resonance imaging) systems installed worldwide. While changes in medical reimbursement have slowed the sale of new MRI machines, there has been an ever increasing demand for improved image quality and reduced patient scan time; thus there has been a tremendous need for products that can improve patient throughput and image quality. OTCBB: MSGL has solved this problem with its low cost software that upgrades existing installed MRI systems to the quality of a new machine at a savings of approximately $1.4 million per machine. The total estimated market for this system is in excess of $1.3B. NASDAQ OTCBB: MSGL is expected to capture approximately 40% of this market within 3 years, resulting in revenues of approximately $500 million, with a Net Margin of approximately 35%, or over $100 million in earnings. Other medical technology / software & system developers such as Baxter Medical NYSE: BAX – p/e of 20X; NASDAQ: NMMD, p/e of 31.4, NASDAQ: NMDC, p/e of 20X; an average of 24X current EPS, and 20X 1 yr forward expected earnings. In comparison to these valuations, NASDAQ OTCBB: MSGL, with its proven market for its product, sales on the books for the current quarter and a successful product launch already would be more fairly valued at 25X –to- 30X forward earnings or $2.00 –to- $3.00 per share currently. For more information, see the company’s website at: microsignalcorp.com/index2.htm ***********************Disclaimer******************** Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will," "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with the Securities Act of 1933, Section 17(b), Emerging Stock Alert discloses the receipt of 250,000 unrestricted shares of MSGL from a third party for the publication of this report. Be aware of an inherent conflict of interest resulting from such compensation due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. All factual information in this report was gathered from public sources, including but not limited to SEC filings, Company Press Releases, and Market Guide. Emerging Equity Alert believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms. ****** Advertising Disclaimer ****** We are an internet advertising company and have received a monetary payment for this mailing service We hold no stocks and have no personal interest in this company whatsoever. We are simply being paid to perform a service. This message is an advertisement. ****** Removal Instructions ****** This message has been sent to you in compliance with our strict anti-abuse regulations. We will continue to bring you valuable offers on the products and services that interest you most. If you do not wish to receive further mailings, please click below. We respect all removal requests. To be removed immediately from our mailing lists just click on the link below: MailTo:jeff6141@inbox.lv?subject=delete Be sure that "delete" is in the subject line of the email prior to sending it. To Unsubscribe: send mail to majordomo@FreeBSD.org with "unsubscribe cvs-all" in the body of the message
Want to link to this message? Use this URL: <https://mail-archive.FreeBSD.org/cgi/mid.cgi?000054665e25$00006b4f$000014ca>